Medical Advisory Board

Diadem is working with a top level international Advisory Board who strongly believes in the technology
Tamas Bartfai

Tamas Bartfai

Ph.D.
Prof. Tamas Bartfai, PhD, is an international leader and expert in the development of drugs targeting neurological diseases. Prof. Bartfai has been involved as a consultant at Astra Zeneca, Roche, Novartis and Pfizer for the past decades. As an executive or consultant, he has been involved in the development of at least eight approved drugs against different neurological diseases. Prof. Bartfai is an Adjunct Professor at Stockholm University, the University of Oxford, and the University of Pennsylvania. He has also been Professor and Chairman of Molecular and Integrative Neurosciences and Director of the Harrold Dorris Neurological Research Institute at the Scripps Research Institute (TSRI), La Jolla, California. Prof. Bartfai’s career is internationally recognized. He is the author of 400+ peer-reviewed publications, several books, and recipient of prestigious awards
Jeffrey Cummings

Jeffrey Cummings

MD, ScD.
Professor of Neurology of the Cleveland Clinic Lerner College of Medicine, Research Professor of the University of Nevada Las Vegas and formerly Professor and researcher at UCLA
Giovanni Frisoni

Giovanni Frisoni

Ph.D. MD.
Professor of Clinical Neuroscience, Head of Memory Clinic, University Hospital of Geneva and University of Geneva. Editor of Neurobiology of Aging in Imaging and an editorial board member for The Lancet Neurology. Principal investigator in important research studies on neuroimaging and the understanding of Alzheimer’s disease
Anne Fagan

Anne Fagan

Ph.D.
Professor of Neurology at Washington University School of Medicine and the Fluid Biomarker Core Leader of several large studies of biomarkers in Alzheimer’s disease